This work was supported by the grants from the National High Technology Research and Development Program of China(No.2001AA215221);the National Natural Science Foundation of China(No.30271184)
To express human papillomavirus (HPV) L 1 capsid protein in the recombinant strain of Shigella and study the potential of a live attenuated Shigella-based HPV prophylactic vaccine in preventing HPV infection, the ic...
Human papillomavirus 6(HPV6) causes a common sexually transmitted disease,the genital warts.L1-capsid protein is a highly promising preventive vaccine that has entered phase Ⅱ clinical trial.But the existing methodol...